TERN-701 Receives FDA Orphan Drug Designation in CML
TERN-701 has received orphan drug designation from the FDA for the treatment of patients with chronic myeloid leukemia.
Source: onclive.com
📰 Allosteric Tkis News
Allosteric Tkis News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Allosteric Tkis. Real-time updates on events, politics, business and more.
Terns Pharmaceuticals Announces Global Phase 1 Clinical Trial Design of TERN-701 for the Treatment of Chronic Myeloid Leukemia
Investigational New Drug application cleared by U.S. Food and Drug Administration Design leverages insights from partner’s ongoing Phase 1 trial in China that support starting dose that appears...
United States Allosteric Tkis Emil Kuriakose Drug Administration Company Investigational New Drug Terns Pharmaceuticals Inc
Source: marketscreener.com
Terns Pharmaceuticals Appoints Emil Kuriakose, M.D., as Chief Medical Officer of Terns Oncology
Experienced Leader Brings Extensive Clinical Development and Medical Affairs Expertise in OncologyFOSTER CITY, Calif., March 27, 2023 -- Terns Pharmaceuticals, Inc. , a clinical-stage... | March 27, 2023
Source: marketscreener.com
Terns Pharmaceuticals Appoints Emil Kuriakose, M.D., as
Experienced Leader Brings Extensive Clinical Development and Medical Affairs Expertise in Oncology...
Source: globenewswire.com